by The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 billion in 2023 and is expected to exhibit a CAGR of 7% over the forecast period of 2023 to 2030, according to a new report published by Coherent Market Insights.
Market Overview:
Automated cell counters are used for precise and rapid counting of cells in a given sample. These instruments provide accurate cell count, save time, and eliminate the risk of human error associated with manual counting. The growing need for efficient and reliable cell counting solutions in research laboratories, hospitals, and diagnostic centers is driving the demand for automated cell counters. These instruments offer advantages such as high accuracy, reproducibility, and ease of use, thereby increasing their adoption in various applications such as cell culture, drug discovery, and clinical diagnostics.
Market Key Trends: Increasing Adoption of Advanced Imaging Technologies
One key trend in the automated cell counters market is the increasing adoption of advanced imaging technologies. Manufacturers are focusing on developing automated cell counters with advanced imaging capabilities, such as fluorescence microscopy and high-resolution imaging, to enhance cell counting accuracy and provide additional insights into cell morphology. These advanced imaging technologies enable better identification of specific cell types and subtypes, aiding in the diagnosis of various diseases and facilitating personalized medicine. Moreover, the integration of artificial intelligence and machine learning algorithms in automated cell counters is further enhancing their capabilities and accuracy in cell counting and analysis. This trend is expected to drive the growth of the automated cell counters market during the forecast period.
Porter’s Analysis
The automated cell counters market is expected to witness high growth, exhibiting a compound annual growth rate (CAGR) of 7% over the forecast period from 2023 to 2030. This growth can be attributed to several factors, including increasing research and development activities in the pharmaceutical and biotechnology industries, rising prevalence of chronic diseases, and a growing demand for personalized medicine.
Threat of new entrants: The threat of new entrants in the automated cell counters market is relatively low. The market is highly regulated, requiring companies to comply with stringent quality and safety standards. Additionally, existing players have established strong distribution networks and brand recognition, making it difficult for new entrants to gain market share.
Bargaining power of buyers: The bargaining power of buyers in the automated cell counters market is moderate. While buyers have access to various suppliers and alternatives, the high cost of switching and the criticality of automated cell counters in research and clinical settings give suppliers some leverage in pricing negotiations.
Bargaining power of suppliers: The bargaining power of suppliers in the automated cell counters market is moderate to high. Suppliers, such as Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies, have established strong positions in the market and offer a wide range of products. However, the presence of multiple suppliers provides buyers with some leverage in terms of pricing and product selection.
Threat of new substitutes: The threat of new substitutes in the automated cell counters market is low. Automated cell counters play a vital role in various applications, including drug discovery, cancer research, and clinical diagnostics. While manual cell counting methods exist, they are time-consuming and less accurate, making automated cell counters the preferred choice for many researchers and clinicians.
Competitive rivalry: The competitive rivalry in the automated cell counters market is high. Key players, such as Thermo Fisher Scientific, Danaher Corporation, and Bio-Rad Laboratories, compete based on factors such as product quality, pricing, and innovation. These companies invest heavily in research and development to launch advanced automated cell counters with improved features and functionalities.
Key Takeaways
The global automated cell counters market is expected to grow at a CAGR of 7% from 2023 to 2030, reaching a market value of US$ 3.75 billion in 2023. This growth can be attributed to the increasing prevalence of chronic diseases and the rising demand for personalized medicine.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the automated cell counters market. The region has a well-developed healthcare infrastructure, a high prevalence of chronic diseases, and a strong presence of key market players.
The key players operating in the automated cell counters market include Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan, and Sartorius AG. These companies focus on product innovation, strategic partnerships, and mergers and acquisitions to maintain their market positions and gain a competitive edge.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
